For research use only. Not for therapeutic Use.
Pivekimab is a human IgG1 monoclonal antibody targeting interleukin 3 (IL-3) and CD123. Pivekimab can be used in the study of blastocytic plasmacytoid dendritic cell tumor (BPDCN)[1].
| Catalog Number | I043170 |
| CAS Number | 2234335-84-1 |
| Purity | ≥95% |
| Reference | [1]. Patrick ZM, et, al. Methods of treatment using anti-CD123 immunoconjugates. WO2020092533. |
